Intriguingly, we found that both knockdown of WHSC1/MMSET and Bortezomib treatment in MM cells were highly related to NFκB signaling and MYC signature in the GSEA analysis (Figure 5B & 5C). The gene discussed is NSD2; the disease is Miyoshi myopathy.